Search

Nuclein Closes $14M in Funding led by Trinity Private Equity Group


AUSTIN, Texas, March 25, 2021 /PRNewswire/ -- Nuclein, LLC has closed a $14 million Series B funding round. The financing helps Nuclein, a medical device company, to commercialize its novel, hand-held PCR platform designed as a disposable, all-in-one, self-test for infectious disease diagnosis.


Continue reading at the link below:

https://www.prnewswire.com/news-releases/nuclein-closes-14m-in-funding-led-by-trinity-private-equity-group-301256242.html